- Home
- GNLX vs WLAC Comparison
GNLX vs WLAC Comparison
Compare GNLX & WLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.73
Company Overview
Basic Information| Metric | GNLX | WLAC |
|---|---|---|
| Founded | 2001 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 219.1M |
| IPO Year | 2023 | 2024 |
Fundamental Metrics
Financial Performance| Metric | GNLX | WLAC |
|---|---|---|
| Price | $4.73 | $11.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 313.6K | 256.8K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $841.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $9.80 |
| 52 Week High | $8.54 | $15.19 |
Technical Indicators
Market Signals| Indicator | GNLX | WLAC |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | N/A |
| Support Level | $4.54 | N/A |
| Resistance Level | $5.89 | N/A |
| Average True Range (ATR) | 0.54 | 0.00 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 11.05 | 0.00 |
Price Performance
Historical Comparison GNLX
WLAC
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About WLAC Willow Lane Acquisition Corp. Class A Ordinary Shares
Willow Lane Acquisition Corp is a blank check company.